ATC B01AC16 · Platelet Aggregation Inhibitors excl. Heparin · updated 2 Nov 2026
Eptifibatide shortage
As of 2 Nov 2026, Eptifibatide has a reported shortage in 2 of the 16 countries we track (Czechia, Australia), covering 2 products from 1 company.
Is there an Eptifibatide shortage?
Yes. As of 2 Nov 2026, Eptifibatide is reported short in 2 of the 16 countries we track: Czechia, Australia. The earliest expected return is 30 Nov 2026 (Czechia). New since 3 Oct 2026: Czechia.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesCompared with similar medicines
ATC group B01AC · Platelet Aggregation Inhibitors excl. HeparinAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | EPTIFIBATIDE ACCORD 2MG/ML 2MG/ML INJ SOL 1X10ML | Accord Healthcare S.L.U., Barcelona | 19 Oct 2026 | 30 Nov 2026 | Manufacturing problem Výrobní důvody |
| AU | EPTIFIBATIDE MEDSURGE eptifibatide (as acetate) 20 mg/10 mL solution for injection vial | 5 Dec 2025 | 31 Mar 2027 | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there an Eptifibatide shortage?
Yes. As of 2 Nov 2026, Eptifibatide is reported short in 2 of the 16 countries we track: Czechia, Australia. The earliest expected return is 30 Nov 2026 (Czechia). New since 3 Oct 2026: Czechia.
When will Eptifibatide be back in stock?
Companies expect supply back from 30 Nov 2026 in Czechia; Czechia: 30 Nov 2026; Australia: 31 Mar 2027. These are company estimates reported to each authority.
Why is Eptifibatide in short supply?
The most common reason reported is: manufacturing problem. Reasons by product are listed in the table below.
Which companies have Eptifibatide shortages?
Accord (Intas).